Tetralogic Pharmaceuticals Corp Stock Nasdaq
Equities
US88165U1097
Biotechnology & Medical Research
Financials (USD)
Sales 2014 | - | Sales 2015 | - | Capitalization | 42.07M |
---|---|---|---|---|---|
Net income 2014 | -36M | Net income 2015 | -49M | EV / Sales 2014 | - |
Net cash position 2014 | 22.32M | Net Debt 2015 | 7.92M | EV / Sales 2015 | - |
P/E ratio 2014 |
-2.96
x | P/E ratio 2015 |
-0.82
x | Employees | - |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
President | - | - | |
Treasurer | 66 | 14-01-31 | |
Dick L. Sherman
SEC | Corporate Secretary | 76 | 12-10-31 |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |